A surveillance and multi drug resistance profile study of extended spectrum beta lactamase producing E. coli in poultry
Arpita Shrivastav, Neeraj Shrivastav, RK Sharma, Vidhi Gautam and Sachin K Jain
Antimicrobial resistance is recognized as a growing global threat. Emergence of antimicrobial resistance in bacteria may be transferred to humans, thereby reducing the effectiveness of antimicrobial drugs for treating human disease. The present study was conducted on extended spectrum beta lactamase producing E. Coli isolated from the caeca of freshly slaughtered healthy broilers. Surveillance in 10 poultry farms was also undertaken. A questionnaire was prepared to get the information about the usage of antibiotics for treatment /prophylaxis/both. Maximum farmers reported that even antibiotics given in the high doses in disease condition are ineffective, which itself reflect the problem of antibiotic resistance. Multi drug resistant profile of ESBL E. coli isolates were also observed against 15 antibioticsand found that ampicillin, cefixime, Ceftriaxone showed 100per cent resistance where as Cefoperazone, Cotrimoxazole, Cefuroxime showed resistance in more than 90 per cent of the isolates. Tetracycline, Ciprofloxacin, Norfloxacin, Netilmicin, Gentamicin, levofloxacin showed resistance of almost 50per cent of the isolates. Chloramphenicol and colistin minimum resistance.
How to cite this article:
Arpita Shrivastav, Neeraj Shrivastav, RK Sharma, Vidhi Gautam, Sachin K Jain. A surveillance and multi drug resistance profile study of extended spectrum beta lactamase producing E. coli in poultry. Pharma Innovation 2018;7(4):613-617.